Clinical trials
Recruiting Gastrointestinal Stromal Tumors trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2013 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Cogent Biosciences, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Deciphera Pharmaceuticals, LLC | 1 |
| Fore Biotherapeutics | 1 |
| Kumquat Biosciences Inc. | 1 |
| Kura Oncology, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Stromal Tumors | 18 |
| Esophageal Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Urinary Bladder Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
| Gallbladder Neoplasms | 3 |
| Gastrointestinal Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.